Small intestinal neuroendocrine tumors: Prognostic factors and survival

References

• Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003; 97: 934–59
   PubMed Web of Science ®Google Scholar
• Modlin IM, Champaneria MC, Chan AK, Kidd M. A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress. Am J Gastroenterol 2007; 102: 1464–73
   PubMed Web of Science ®Google Scholar
• Hauso Ø, Gustafsson BI, Kidd M, Waldum HL, Drozdov I, Chan AK, et al. Neuroendocrine tumor epidemiology: contrasting Norway and North America. Cancer 2008; 113: 2655–64
   PubMed Web of Science ®Google Scholar
• Modlin IM, Kidd M, Latich I, Zikusoka MN, Shapiro MD. Current status of gastrointestinal carcinoids. Gastroenterology 2005; 128: 1717–51
   PubMed Web of Science ®Google Scholar
• Oberndorfer S. Karzinoide Tumoren des Dunndarms. Frank Z Pathol 1907; 1: 426–29
   Google Scholar
• Williams ED, Sandler M. The classification of carcinoid tumours. Lancet 1963; 1: 238–39
   PubMed Web of Science ®Google Scholar
• Maggard MA, O'Connell JB, Ko CY. Updated population-based review of carcinoid tumors. Ann Surg 2004; 240: 117–22
   PubMed Web of Science ®Google Scholar
• Zar N, Garmo H, Holmberg L, Rastad J, Hellman P. Long-term survival of patients with small intestinal carcinoid tumors. World J Surg 2004; 28: 1163–8
   PubMed Web of Science ®Google Scholar
• Tomassetti P, Campana D, Piscitelli L, Casadei R, Nori F, Brocchi E, et al. Endocrine tumors of the ileum: factors correlated with survival. Neuroendocrinology 2006; 83: 380–86
   PubMed Web of Science ®Google Scholar
• Eriksson B, Oberg K, Stridsberg M. Tumor markers in neuroendocrine tumors. Digestion ; 62 Suppl 2000; 1: 33–8
   Web of Science ®Google Scholar
• Janson ET, Holmberg L, Stridsberg M, Eriksson B, Theodorsson E, Wilander E, et al. Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center. Ann Oncol 1997; 8: 685–90
   PubMed Web of Science ®Google Scholar
• Zimmermann ME, Bosman FT. Proliferative activity of well differentiated neuroendocrine tumours of the gut. Histol Histopathol 2003; 18: 353–8
   PubMed Web of Science ®Google Scholar
• Reeves GK, Beral V, Bull D, Quinn M. Estimating relative survival among people registered with cancer in England and Wales. Br J Cancer 1999; 79: 18–22
   PubMed Web of Science ®Google Scholar
• Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med 2004; 23: 51–64
   PubMed Web of Science ®Google Scholar
• Kirkwood BR, Sterne JAC. Essential medical statistics2nd ed. Blackwell Science, Malden, Massachusetts 2003
   Google Scholar
• Cook NR. Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve. Clin Chem 2008; 54: 17–23
   PubMed Web of Science ®Google Scholar
• Søreide K. Receiver-operating characteristic curve analysis in diagnostic, prognostic and predictive biomarker research. J Clin Pathol 2009; 62: 1–5
   PubMed Web of Science ®Google Scholar
• Burke AP, Thomas RM, Elsayed AM, Sobin LH. Carcinoids of the jejunum and ileum: an immunohistochemical and clinicopathologic study of 167 cases. Cancer 1997; 79: 1086–93
   PubMed Web of Science ®Google Scholar
• Quaedvlieg PF, Visser O, Lamers CB, Janssen-Heijen ML, Taal BG. Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiological study with 2391 patients. Ann Oncol 2001; 12: 1295–300
   PubMed Web of Science ®Google Scholar
• Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, et al. One hundred years after “carcinoid”: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008; 26: 3063–72
   PubMed Web of Science ®Google Scholar
• Ihse I. The volume-outcome relationship in cancer surgery: a hard sell. Ann Surg 2003; 238: 777–81
   PubMed Web of Science ®Google Scholar
• Vernooij F, Heintz AP, Witteveen PO, van der Heiden-van der Loo M, Coebergh JW, van der Graaf Y. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study. J Natl Cancer Inst 2008; 100: 399–406
   PubMedGoogle Scholar
• Moertel C, Sauer W, Dockerty M, Baggenstoss H. Life history of the carcinoid tumor of the small intestine. Cancer 1961; 14: 901–12
   PubMed Web of Science ®Google Scholar
• Makridis C, Öberg K, Juhlin C, Rastad J, Johansson H, Lorelius LE, et al. Surgical treatment of mid-gut carcinoid tumors. World J Surg 1990; 14: 377–85
   PubMed Web of Science ®Google Scholar
• de Herder WW. Tumours of the midgut (jejunum, ileum and ascending colon, including carcinoid syndrome). Best Pract Res Clin Gastroenterol 2005; 19: 705–15
   PubMed Web of Science ®Google Scholar
• Kulke MH. Neuroendocrine tumours: clinical presentation and management of localized disease. Cancer Treat Rev 2003; 29: 363–70
   PubMed Web of Science ®Google Scholar
• Denney WD, Kemp WE, LB, Jr, Anthony JA, Oates BF, Byrd III. Echocardiographic and biochemical evaluation of the development and progression of carcinoid heart disease. J Am Coll Cardiol 1998; 32: 1017–22
   PubMed Web of Science ®Google Scholar
• Jacobsen MB, Nitter-Hauge S, Bryde PE, Hanssen LE. Cardiac manifestations in mid-gut carcinoid disease. Eur Heart J 1995; 16: 51–6
   PubMed Web of Science ®Google Scholar
• Møller JE, Connolly HM, Rubin J, Seward JB, Modesto K, Pellikka PA. Factors associated with progression of carcinoid heart disease. N Engl J Med 2003; 348: 1005–15
   PubMed Web of Science ®Google Scholar
• Pellikka PA, Tajik AJ, Khandheria BK, Seward JB, Callahan JA, Pitot HC, et al. Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients. Circulation 1993; 87: 1188–96
   PubMed Web of Science ®Google Scholar
• Westberg G, Wangberg B, Ahlman H, Bergh CH, Beckman-Suurkula M, Caidahl K. Prediction of prognosis by echocardiography in patients with midgut carcinoid syndrome. Br J Surg 2001; 88: 865–72
   PubMed Web of Science ®Google Scholar
• Bergestuen, DA, Thiis-Evensen, E, Edvardsen, T, Aakhus, S, Aukrust, P, Ueland, T, , et al. Markers of fibrosis in carcinoid heart disease. 5th Annual ENETS Conference 2008 [abstract C6].
   Google Scholar
• Bonfrer, J, Korse, C, Taal, B. Follow-up of patients with carcinoid tumors. 3rd Annual ENETS Conference. 2006, [abstract C8].
   Google Scholar
• Zuetenhorst JM, Bonfrer JM, Korse CM, Bakker R, van Tinteren H, Taal BG. Carcinoid heart disease: the role of urinary 5-hydroxyindoleacetic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-beta and fibroblast growth factor. Cancer 2003; 97: 1609–15
   PubMed Web of Science ®Google Scholar
• Bhattacharyya S, Toumpanakis C, Caplin ME, Davar J. Analysis of 150 patients with carcinoid syndrome seen in a single year at one institution in the first decade of the twenty-first century. Am J Cardiol 2008; 101: 378–81
   PubMed Web of Science ®Google Scholar
• Ross EM, Roberts WC. The carcinoid syndrome: comparison of 21 necropsy subjects with carcinoid heart disease to 15 necropsy subjects without carcinoid heart disease. Am J Med 1985; 79: 339–54
   PubMed Web of Science ®Google Scholar
• Hellman P, Lundstrom T, Ohrvall U, Eriksson B, Skogseid B, Oberg K, et al. Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases. World J Surg 2002; 26: 991–7
   PubMed Web of Science ®Google Scholar